Thrivent Financial for Lutherans’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-30,009
| Closed | -$123K | – | 2596 |
|
2024
Q1 | $123K | Hold |
30,009
| – | – | ﹤0.01% | 2485 |
|
2023
Q4 | $126K | Sell |
30,009
-1,465
| -5% | -$6.15K | ﹤0.01% | 2458 |
|
2023
Q3 | $136K | Sell |
31,474
-54,953
| -64% | -$237K | ﹤0.01% | 2403 |
|
2023
Q2 | $570K | Sell |
86,427
-2,868
| -3% | -$18.9K | ﹤0.01% | 2132 |
|
2023
Q1 | $606K | Sell |
89,295
-1,772
| -2% | -$12K | ﹤0.01% | 2047 |
|
2022
Q4 | $673K | Sell |
91,067
-421
| -0.5% | -$3.11K | ﹤0.01% | 1965 |
|
2022
Q3 | $904K | Buy |
91,488
+35,989
| +65% | +$356K | ﹤0.01% | 1747 |
|
2022
Q2 | $605K | Buy |
55,499
+10,145
| +22% | +$111K | ﹤0.01% | 2007 |
|
2022
Q1 | $513K | Buy |
45,354
+15
| +0% | +$170 | ﹤0.01% | 2183 |
|
2021
Q4 | $711K | Buy |
45,339
+366
| +0.8% | +$5.74K | ﹤0.01% | 2044 |
|
2021
Q3 | $771K | Sell |
44,973
-449
| -1% | -$7.7K | ﹤0.01% | 1976 |
|
2021
Q2 | $977K | Buy |
45,422
+337
| +0.7% | +$7.25K | ﹤0.01% | 1859 |
|
2021
Q1 | $677K | Sell |
45,085
-185
| -0.4% | -$2.78K | ﹤0.01% | 2094 |
|
2020
Q4 | $595K | Sell |
45,270
-132
| -0.3% | -$1.74K | ﹤0.01% | 2055 |
|
2020
Q3 | $439K | Hold |
45,402
| – | – | ﹤0.01% | 2032 |
|
2020
Q2 | $519K | Buy |
45,402
+701
| +2% | +$8.01K | ﹤0.01% | 1892 |
|
2020
Q1 | $463K | Buy |
44,701
+2,231
| +5% | +$23.1K | ﹤0.01% | 1756 |
|
2019
Q4 | $697K | Buy |
42,470
+189
| +0.4% | +$3.1K | ﹤0.01% | 1700 |
|
2019
Q3 | $561K | Buy |
42,281
+981
| +2% | +$13K | ﹤0.01% | 1768 |
|
2019
Q2 | $582K | Buy |
41,300
+1,214
| +3% | +$17.1K | ﹤0.01% | 1735 |
|
2019
Q1 | $738K | Buy |
40,086
+3,012
| +8% | +$55.5K | ﹤0.01% | 1571 |
|
2018
Q4 | $969K | Buy |
37,074
+815
| +2% | +$21.3K | ﹤0.01% | 1173 |
|
2018
Q3 | $832K | Buy |
+36,259
| New | +$832K | ﹤0.01% | 1409 |
|
2016
Q1 | – | Sell |
-93,060
| Closed | -$866K | – | 2029 |
|
2015
Q4 | $866K | Buy |
+93,060
| New | +$866K | ﹤0.01% | 1115 |
|